Randomized, double-blind placebo-controlled trial to evaluate the safety and immunogenicity of combined Salmonella typhi Ty21a and Vibrio cholerae CVD 103-HgR live oral vaccines.

Healthy adults (n=330) were randomized to receive either a bivalent vaccine composed of Vibrio cholerae CVD 103-HgR and Salmonella typhi Ty21a or a placebo. The combined vaccine was well tolerated. Approximately 80% of vaccines manifested a significant rise in anti-S. typhi immunoglobulin G or immun...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Infect Immun
Principais autores:	Kollaritsch, H, Furer, E, Herzog, C, Wiedermann, G, Que, J U, Cryz, S J
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1996
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC173943/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8606118/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.64.4.1454-1457.1996
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!